259 related articles for article (PubMed ID: 3813669)
1. Behçet's disease in Iraqi patients.
Al-Rawi ZS; Sharquie KE; Khalifa SJ; Al-Hadithi FM; Munir JJ
Ann Rheum Dis; 1986 Dec; 45(12):987-90. PubMed ID: 3813669
[TBL] [Abstract][Full Text] [Related]
2. The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey.
Mizuki Y; Horita N; Horie Y; Takeuchi M; Ishido T; Mizuki R; Kawagoe T; Shibuya E; Yuda K; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Fukumoto T; Kurosawa M; Kitaichi N; Takeno M; Kaneko T; Mizuki N
Mod Rheumatol; 2020 Jul; 30(4):708-714. PubMed ID: 31386589
[No Abstract] [Full Text] [Related]
3. The pathergy test and Behçet's syndrome in Britain.
Davies PG; Fordham JN; Kirwan JR; Barnes CG; Dinning WJ
Ann Rheum Dis; 1984 Feb; 43(1):70-3. PubMed ID: 6696521
[TBL] [Abstract][Full Text] [Related]
4. Relationships of HLA-B51 or B5 genotype with Behcet's disease clinical characteristics: systematic review and meta-analyses of observational studies.
Maldini C; Lavalley MP; Cheminant M; de Menthon M; Mahr A
Rheumatology (Oxford); 2012 May; 51(5):887-900. PubMed ID: 22240504
[TBL] [Abstract][Full Text] [Related]
5. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
[TBL] [Abstract][Full Text] [Related]
6. Behçet's disease in Tunisia. Demographic, clinical and genetic aspects in 260 patients.
Houman MH; Neffati H; Braham A; Harzallah O; Khanfir M; Miled M; Hamzaoui K
Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S58-64. PubMed ID: 17949553
[TBL] [Abstract][Full Text] [Related]
7. The relationship between plasma homocysteine level and HLA-B51 in patients with Behcet's disease: a case-control study.
Shadmanfar S; Shahram F; Nadji A; Akhlaghi M; Faezi ST; Sadeghi-Abdollahi B; Faridar A; Madanchi N; Davatchi F
Int J Rheum Dis; 2014 May; 17(4):466-70. PubMed ID: 24428874
[TBL] [Abstract][Full Text] [Related]
8. Dose HLA-B5, 7, 8, 27, and 51 Antigens Associated to Behcet's disease? A Study in Southwestern Iran.
Rajaei E; Jalali MT; Pezeshki SMS; Rezaeeyan H; Maniati M; Elyasi M; Zayeri ZD
Curr Rheumatol Rev; 2020; 16(2):120-124. PubMed ID: 31533601
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Hla-B51 in the susceptibility and specific clinical features of Behcet's disease in Tunisian patients.
Hamzaoui A; Houman MH; Massouadia M; Ben Salem T; Khanfir MS; Ben Ghorbel I; Miled M
Eur J Intern Med; 2012 Jun; 23(4):347-9. PubMed ID: 22560383
[TBL] [Abstract][Full Text] [Related]
10. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
[TBL] [Abstract][Full Text] [Related]
11. HLA-B51 and its allelic types in association with Behçet's disease and recurrent aphthous stomatitis in Korea.
Chang HK; Kim JU; Cheon KS; Chung HR; Lee KW; Lee IH
Clin Exp Rheumatol; 2001; 19(5 Suppl 24):S31-5. PubMed ID: 11760395
[TBL] [Abstract][Full Text] [Related]
12. Audio-vestibular disturbances in Behcet's patients: report of 62 cases.
Kulahli I; Balci K; Koseoglu E; Yuce I; Cagli S; Senturk M
Hear Res; 2005 May; 203(1-2):28-31. PubMed ID: 15855027
[TBL] [Abstract][Full Text] [Related]
13. HLA-B27 and HLA-B51 determination in Tunisian healthy subjects and patients with suspected ankylosing spondylitis and Behçet's disease.
Sakly N; Boumiza R; Zrour-Hassen S; Hamzaoui A; Ben Yahia S; Amara H; Khairallah M; Mahjoub S; Bergaoui N; Ghedira I
Ann N Y Acad Sci; 2009 Sep; 1173():564-9. PubMed ID: 19758200
[TBL] [Abstract][Full Text] [Related]
14. A strong association between HLA-B*5101 and Behçet's disease in Greek patients.
Mizuki N; Ohno S; Ando H; Chen L; Palimeris GD; Stavropoulos-Ghiokas E; Ishihara M; Goto K; Nakamura S; Shindo Y; Isobe K; Ito N; Inoko H
Tissue Antigens; 1997 Jul; 50(1):57-60. PubMed ID: 9243757
[TBL] [Abstract][Full Text] [Related]
15. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease.
Paul M; Klein T; Krause I; Molad Y; Narinsky R; Weinberger A
Tissue Antigens; 2001 Sep; 58(3):185-6. PubMed ID: 11703827
[TBL] [Abstract][Full Text] [Related]
16. HLA-B51 may serve as an immunogenetic marker for a subgroup of patients with Behçet's syndrome.
Chajek-Shaul T; Pisanty S; Knobler H; Matzner Y; Glick M; Ron N; Rosenman E; Brautbar C
Am J Med; 1987 Oct; 83(4):666-72. PubMed ID: 3314492
[TBL] [Abstract][Full Text] [Related]
17. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians.
Baricordi OR; Sensi A; Pivetti-Pezzi P; Perrone S; Balboni A; Catarinelli G; Filippi F; Melchiorri L; Moncada A; Mattiuz PL
Hum Immunol; 1986 Nov; 17(3):297-301. PubMed ID: 2432045
[TBL] [Abstract][Full Text] [Related]
18. Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.
Ishido T; Horita N; Takeuchi M; Kawagoe T; Shibuya E; Yamane T; Hayashi T; Meguro A; Ishido M; Minegishi K; Yoshimi R; Kirino Y; Kato S; Arimoto J; Ishigatsubo Y; Takeno M; Kurosawa M; Kaneko T; Mizuki N
Rheumatology (Oxford); 2017 Nov; 56(11):1918-1927. PubMed ID: 28968732
[TBL] [Abstract][Full Text] [Related]
19. HLA-B*5101 in Greek patients with Behçet's disease.
Koumantaki Y; Stavropoulos C; Spyropoulou M; Messini H; Papademetropoulos M; Giziaki E; Marcomichelakis N; Palimeris G; Kaklamanis P; Kaklamani E
Hum Immunol; 1998 Apr; 59(4):250-5. PubMed ID: 9568801
[TBL] [Abstract][Full Text] [Related]
20. Lack of association of HLA-B*51 with a severe disease course in Behçet's disease.
Gül A; Uyar FA; Inanc M; Ocal L; Tugal-Tutkun I; Aral O; Koniçe M; Saruhan-Direskeneli G
Rheumatology (Oxford); 2001 Jun; 40(6):668-72. PubMed ID: 11426025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
